Company intelligence / Profile preview

Newstar Ventures

London, England, United Kingdomnewstarventures.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Newstar Ventures is an internationally oriented investment fund providing direct investments and advisory services to companies in the life sciences, technology, and related sectors. The firm has built a diverse portfolio across public and private markets globally over the past decade. It is led by experienced executives with deep backgrounds in life science operations and venture capital.

Industry: Investors

Drug pipeline

4 assets

BB-401

Phase 2

Indications: Head and neck squamous cell carcinoma

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Newstar Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Newstar Ventures.

Explore the full profile